Chlamydia vaccine (Chlamydia trachomatis serovar E polypeptide MOMP, Endocine adjuvant) (Spixia/Eurocine Vaccines/Orebro University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameChlamydia vaccine (Chlamydia trachomatis serovar E polypeptide MOMP, Endocine adjuvant) (Spixia/Eurocine Vaccines/Orebro University)
Drug Alias NameChlamydia vaccine (Chlamydia trachomatis serovar E polypeptide MOMP, Endocine adjuvant) (Spixia/Eurocine Vaccines)sexually transmitted bacterial diseases vaccine (injectable/Endocine adjuvant) (Eurocine Vaccines)Chlamydia vaccine (chlamydia trachomatis serovar E polypeptide MOMP) (Spixia/Eurocine Vaccines/Orebro University)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine +[5] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsChlamydia Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusSuspended
Highest Status in ChinaN/A
Originator CompaniesSpixia Biotechnology AB
China Registration ClassN/A

Develop Information

Active CompaniesOrebro UniversitetSpixia Biotechnology ABEurocine Vaccines Ab
Inactive CompaniesN/A
Active IndicationsChlamydia Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A